102460.KS
REYON Pharmaceutical Co., Ltd.
KSC · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 9,360.00
−3.31%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.89x
- Price / sales
- 1.21x
- Price / cash flow
- 29.24x
Enterprise value
- Enterprise value
- KRW 383.8B
- EV / sales
- 2.68x
- EV / EBITDA
- -24.89x
- EV / EBIT
- -12.77x
- Market cap
- KRW 174.0B
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026